Statement of Organization, Functions, and Delegations of Authority, 37080 [06-5785]
Download as PDF
<![CDATA[
37080
Federal Register / Vol. 71, No. 125 / Thursday, June 29, 2006 / Notices
of their qualifications (in particular,
those that address the required
qualifications, outlined above) and the
current expertise needs of the Task
Force. It is anticipated that 2
individuals will be invited to serve on
the Task Force beginning in January,
2007. AHRQ will retain and consider for
future vacancies the nominations of
those not selected during this cycle.
Submit your response to:
Helen Burstin, MD MPH, ATTN:
USPSTF Nominations, Center for
Primary Care, Prevention, and Clinical
Partnerships, Agency for Healthcare
Research and Quality, 540 Gaither Road,
Rockville, Maryland 20850.
ADDRESSES:
Nomination Submissions
Nominations may submitted in
writing or electronically, but must
include (1) the applicant’s current
curriculum vitae, and (2) a letter
explaining how this individual meets
the qualification requirements and how
he/she would contribute to the Task
Force. The letter should also attest to
the nominee’s willingness to serve as a
member of the Task Force.
AHRQ will later ask persons under
serious consideration for membership to
provide detailed information that will
permit evaluation of possible significant
conflicts of interest. Such information
will concern matters such as financial
holdings, consultancies, and research
grants or contracts.
Nomination Selection
Nominations for the Task Force will
be selected on the basis of qualifications
as outlined above (see qualification
requirements) and the current expertise
needs of the Task Force.
jlentini on PROD1PC65 with NOTICES
Arrangement for Public Inspection
Nominations and applications are
kept on file at the Center for Primary
Care, Prevention and Clinical
Partnerships, and are available for
review during business hours. AHRQ
does not reply to individual responses,
but considers all nominations in
selecting members. Information
regarded as private and personal, such
as a nominee’s social security number,
home and internet addresses, home
telephone and fax numbers, or names of
family members will not be disclosed to
the public. This is in accord with
agency confidentiality policies and
Department regulations (45 CFR 5.67).
FOR FURTHER INFORMATION CONTACT:
Therese Miller at
therese.miller@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
VerDate Aug<31>2005
17:03 Jun 28, 2006
Jkt 208001
Background
Under Title IX of the Public Health
Service Act, AHRQ is charged with
enhancing the quality, appropriateness,
and effectiveness of health care services
and access to such services. AHRQ
accomplishes these goals through
scientific research and promotion of
improvements in clinical practice,
including prevention of diseases and
other health conditions, and
improvements in the organization,
financing, and delivery of health care
services (42 U.S.C. 299–299c–7 as
amended).
The Task Force is an independent
expert panel, first established in 1984
under the auspices of the U.S. Public
Health Service, Currently, the USPSTF,
under AHRQ’s authorizing legislation
(see in particular, 42 U.S.C. 299b–4(a)),
is convened at the call of the Director of
AHRQ. The Task Force is charged with
rigorously evaluating the effectiveness,
cost-effectiveness and appropriateness
of clinical preventive services and
formulating or updating
recommendations for primary are
clinicians regarding the appropriate
provision of preventive services. The
USPSTF transitioned to a standing Task
Force in 2001. Current Task Force
recommendations and associated
evidence reviews are available on the
Internet (https://
www.preventiveservices.ahrq.gov).
Dated: June 22, 2006.
Carolyn M. Clancy,
Director.
[FR Doc. 06–5782 Filed 6–28–06; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 71 FR 32349–32350,
dated June 5, 2006) is amended to
reflect the reorganization of the Office of
the Chief Science Officer, Office of the
Director, Centers for Disease Control
and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Revise the functional statement for
the Office of the Chief Science Officer
(CAS), as follows:
After item (12), insert the following
item: (13) provides oversight, training,
monitoring, and quality assurance in the
use of animals in research.
Delete item (10) of the functional
statement for the Scientific Resources
Program (CVCE), National Center for
Infectious Diseases (CVC), and
renumber the remaining items
accordingly.
Dated: June 22, 2006.
William H. Gimson,
Chief Operating Officer, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 06–5785 Filed 6–28–06; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N–0021]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Request for
Samples and Protocols
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by July 31,
2006.
ADDRESSES: OMB is still experiencing
significant delays in the regular mail,
including first class and express mail,
and messenger deliveries are not being
accepted. To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of Management
Programs (HFA–250), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–827–4659.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
E:\FR\FM\29JNN1.SGM
29JNN1
]]>Agencies
[Federal Register Volume 71, Number 125 (Thursday, June 29, 2006)]
[Notices]
[Page 37080]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-5785]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 71 FR 32349-32350, dated June 5, 2006) is
amended to reflect the reorganization of the Office of the Chief
Science Officer, Office of the Director, Centers for Disease Control
and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows:
Revise the functional statement for the Office of the Chief Science
Officer (CAS), as follows:
After item (12), insert the following item: (13) provides
oversight, training, monitoring, and quality assurance in the use of
animals in research.
Delete item (10) of the functional statement for the Scientific
Resources Program (CVCE), National Center for Infectious Diseases
(CVC), and renumber the remaining items accordingly.
Dated: June 22, 2006.
William H. Gimson,
Chief Operating Officer, Centers for Disease Control and Prevention
(CDC).
[FR Doc. 06-5785 Filed 6-28-06; 8:45 am]
BILLING CODE 4160-18-M
